More good news: Novavax vaccine candidate looks good

This would be another vaccine offering available later in 2021 – more trials are still underway in the U.S.

Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work — though not quite as well — against new mutated strains of the virus circulating in that country and South Africa.

Source: Novavax vaccine seems effective against COVID-19 in UK study | KATU